Cargando…
Pharmacological cardioversion of supraventricular tachycardia in pregnancy during continuous electrophysiological foetal monitoring: a case report
BACKGROUND: Maternal tachycardia is the most frequently occurring cardiac complication during pregnancy. Often administration of drugs is required as a treatment. The drug of choice is intravenously administered adenosine because it is considered safe, though there are limited studies regarding safe...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168670/ https://www.ncbi.nlm.nih.gov/pubmed/35673277 http://dx.doi.org/10.1093/ehjcr/ytac213 |
_version_ | 1784721055550537728 |
---|---|
author | Francinetti, Audrey Vullings, Rik Dewals, Wendy Jochems, Lisbeth |
author_facet | Francinetti, Audrey Vullings, Rik Dewals, Wendy Jochems, Lisbeth |
author_sort | Francinetti, Audrey |
collection | PubMed |
description | BACKGROUND: Maternal tachycardia is the most frequently occurring cardiac complication during pregnancy. Often administration of drugs is required as a treatment. The drug of choice is intravenously administered adenosine because it is considered safe, though there are limited studies regarding safety for the foetus with the use of adenosine. CASE SUMMARY: We report a conversion of maternal atrio-ventricular (AV) nodal reentry tachycardia during pregnancy with the use of intravenous adenosine whilst continuous electrophysiological foetal monitoring. Four seconds after the maternal conversion, the foetal tracing suggests the presence of a ventricular extrasystole or a transient AV block. DISCUSSION: This case report illustrates that the administration of adenosine intravenously during pregnancy could have an effect on the foetal conduction system. Therefore, further investigation to assess the electrophysiological effect of adenosine on the foetal electrocardiogram seems required. |
format | Online Article Text |
id | pubmed-9168670 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-91686702022-06-06 Pharmacological cardioversion of supraventricular tachycardia in pregnancy during continuous electrophysiological foetal monitoring: a case report Francinetti, Audrey Vullings, Rik Dewals, Wendy Jochems, Lisbeth Eur Heart J Case Rep Case Report BACKGROUND: Maternal tachycardia is the most frequently occurring cardiac complication during pregnancy. Often administration of drugs is required as a treatment. The drug of choice is intravenously administered adenosine because it is considered safe, though there are limited studies regarding safety for the foetus with the use of adenosine. CASE SUMMARY: We report a conversion of maternal atrio-ventricular (AV) nodal reentry tachycardia during pregnancy with the use of intravenous adenosine whilst continuous electrophysiological foetal monitoring. Four seconds after the maternal conversion, the foetal tracing suggests the presence of a ventricular extrasystole or a transient AV block. DISCUSSION: This case report illustrates that the administration of adenosine intravenously during pregnancy could have an effect on the foetal conduction system. Therefore, further investigation to assess the electrophysiological effect of adenosine on the foetal electrocardiogram seems required. Oxford University Press 2022-05-24 /pmc/articles/PMC9168670/ /pubmed/35673277 http://dx.doi.org/10.1093/ehjcr/ytac213 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the European Society of Cardiology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Case Report Francinetti, Audrey Vullings, Rik Dewals, Wendy Jochems, Lisbeth Pharmacological cardioversion of supraventricular tachycardia in pregnancy during continuous electrophysiological foetal monitoring: a case report |
title | Pharmacological cardioversion of supraventricular tachycardia in pregnancy during continuous electrophysiological foetal monitoring: a case report |
title_full | Pharmacological cardioversion of supraventricular tachycardia in pregnancy during continuous electrophysiological foetal monitoring: a case report |
title_fullStr | Pharmacological cardioversion of supraventricular tachycardia in pregnancy during continuous electrophysiological foetal monitoring: a case report |
title_full_unstemmed | Pharmacological cardioversion of supraventricular tachycardia in pregnancy during continuous electrophysiological foetal monitoring: a case report |
title_short | Pharmacological cardioversion of supraventricular tachycardia in pregnancy during continuous electrophysiological foetal monitoring: a case report |
title_sort | pharmacological cardioversion of supraventricular tachycardia in pregnancy during continuous electrophysiological foetal monitoring: a case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168670/ https://www.ncbi.nlm.nih.gov/pubmed/35673277 http://dx.doi.org/10.1093/ehjcr/ytac213 |
work_keys_str_mv | AT francinettiaudrey pharmacologicalcardioversionofsupraventriculartachycardiainpregnancyduringcontinuouselectrophysiologicalfoetalmonitoringacasereport AT vullingsrik pharmacologicalcardioversionofsupraventriculartachycardiainpregnancyduringcontinuouselectrophysiologicalfoetalmonitoringacasereport AT dewalswendy pharmacologicalcardioversionofsupraventriculartachycardiainpregnancyduringcontinuouselectrophysiologicalfoetalmonitoringacasereport AT jochemslisbeth pharmacologicalcardioversionofsupraventriculartachycardiainpregnancyduringcontinuouselectrophysiologicalfoetalmonitoringacasereport |